Hope for people with multiple sclerosis

Hope for people with multiple sclerosis
13.05.2019
CCSVI
Author: CCSVI Clinic

Multiple sclerosis is a disease of unknown origin. Currently, it is supposed to have an autoimmune basis. This means that the patient's immune system fights cells of his own body. The disease mainly affects young people between 20 and 40 years of age, with women suffering more often than men.

In fact, multiple sclerosis is a disease that we know little about. Currently, medicine is trying to relieve the symptoms of MS with medicines. Meanwhile, in many countries, the search for causes of this disease and alternative forms of therapy is underway. In 2009, it was noticed that many patients with multiple sclerosis had problems with blood circulation. The venous system responsible for draining blood from the brain and spinal cord works badly. As a result, blood in the brain leads to inflammation, and these induce neurological symptoms associated with MS.

The phenomenon of chronic venous disorders is called CCSVI. Unfortunately, the attempts to open the venous system so far have only been limited to a small section of the blood vessels. Only the jugular veins were operated, omitting the rest of the system. The effects of such treatments were different, which made doctors believe that they are ineffective. So far, however, no one has tried to assess the effectiveness of therapy involving the entire venous system.

In 2017 at the CCSVI Clinic, a research project on vein clearing of patients with multiple sclerosis was initiated. It is fundamentally different from the treatments performed so far. The clinic restores proper blood circulation from the vessels inside the skull to the renal vein. Due to the fact that no one in the world has ever conducted such advanced research on CCSVI and its association with MS, all treatments are performed with the consent of the Bioethics Committee at the Research and Development Center of the Provincial Specialist Hospital in Wroclaw.

 

What is the CCSVI research project?

 

The program developed by doctors from CCSVI Clinic, including the diagnosis and therapy of venous insufficiency, is currently the most advanced project of this type in the world. The venous system is examined using 3-Tesla magnetic resonance and IVUS intravascular ultrasound. In addition, the pressure gradient in the veins is measured. The combination of these three tools allows you to detect irregularities that were previously invisible.

Diagnostics of the venous system is the first stage of the study. After it follows the therapeutic part. Patients undergo vein clearing procedures in areas where abnormalities have previously been detected. Thanks to the advanced technology that allows combining images from magnetic resonance and angiography, the duration of the treatment and the radiation dose are reduced to a minimum. Nevertheless, it is a complicated neurosurgical operation that can last up to several hours. In each case, the procedure is carried out under general anesthesia.

Both the holistic approach to the venous system and the use of state-of-the-art research tools make this project the only such venture in the world.

 

Medical staff and safety conditions

 

The team of doctors consists of top-class neurologists, neurosurgeons and interventional radiologists. In 2018 two specialists of international renown joined the CCSVI Clinic. The first of them is prof. Salvatore Sclafani, surgeon and interventional radiologist with over 40 years of experience, considered one of the best vascular surgeons in New York. The second is Dr Franz Schelling - Austrian intervention radiologist, a global authority in the field of CCSVI diagnosis.

Diagnostics and treatments are conducted at the HCP Medical Center in Poznan. The patient stays in the hospital for 2 to 3 days.

 

Who can participate in the program?

 

People suffering from MS who have been diagnosed with venous deformities characteristic of CCSVI. The most promising patients are people at an early stage of the disease. In their case, therapy brings the best results. Each patient qualified for the program is subject to a 3-year observation, aimed at assessing the degree and durability of the effects of the treatment.

The research project is carried out on a commercial basis. In Poland, similarly to other places in the world, such treatments are not yet refunded. The money for the treatment may come from the patient's own resources or may be obtained by foundations and public benefit organizations. To date, many patients have been operated on CCSVI Clinic and foundations for this purpose. However, the interest was so great that the number entered on the waiting list exceeded 100 people. Further subscriptions for free operations have been paused.

 

Summary

 

By joining the program you need to be aware that you are participating in an innovative project that has not been carried out anywhere else in the world. The results of the study will be used to assess the relationship between multiple sclerosis and chronic venous insufficiency. Until the end of the study, it is not possible to determine to what extent such treatments affect the patient's health.

 

More information about the course of therapy can be obtained on our website:

Therapeutic and research programme

 

Below are the reports of the first patients:

Patients feedback